Home Search
chemotherapy - search results
If you're not happy with the results, please do another search
New data reveals cancer diagnosis could affect treatment options
Data from Public Health England shows that cancer diagnosis could impact upon which kind of treatment a patient receives.
The challenge of curing cancer in the world’s children
Dr Martin English, Consultant Paediatric Oncologist and member of the Royal College of Paediatrics and Child Health (RCPCH) explains the challenge of curing cancer in the world’s children
Improving acute myeloid leukaemia (AML) outcomes
Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores how outcomes for acute myeloid leukaemia (AML) can be improved
Disease-associated myosteatosis in people with cancer: Can it be treated?
Can we prevent the muscle loss associated with some cancers? Dr Vera Mazurak at the University of Alberta is looking into one method of treating myosteatosis
Pathological fat infiltration into muscle is a feature of disease-induced muscle loss that significantly associates with shorter survival in people with cancer. Fat is...
Cancer immunotherapy therapy is here and now
Stephanie K. Watkins PhD from Loyola University Chicago shares her views on cancer immunotherapy therapy – the concept of using the immune system to fight and destroy cancer cells
Is 2018 the year we will see a cure for Thalassemia?
Multiple breakthroughs in gene therapy offer new hope for patients with genetic blood disorder, most common in Middle Eastern, Mediterranean, South Asian and African populations
The role of advanced technologies in healthcare
The role of advanced technologies in healthcare, including the work of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in this area, is placed under the spotlight by Open Access Government
Cancer research and training in the United States
The work of the National Cancer Institute (NCI), the federal government’s principal agency for cancer research and training in the United States, is profiled here by Open Access Government
The illusion of cancer and death: Illusion of the self
Sumith A Kularatne, PhD, discusses his thoughts on the illusion of cancer and death
Paediatric sarcoma metastasis: an area that warrants in-depth exploration
Ivan Stamenkovic, Professor of Experimental Pathology at University of Lausanne explores the paediatric sarcoma metastasis and why this warrants an in-depth look
Metastasis is responsible for 90% of cancer–related death. Several solid paediatric malignancies, particularly sarcomas, display high metastatic proclivity, which renders their prognosis poor, as metastases are for the...
From wheelchair to high heels: Realising the potential of stem cells
Dr Michael A Rudnicki, CEO & Scientific Director at the Stem Cell Network gives an expert view on a new era in health care, powered by stem cells
Acute leukemia – driving toward precision and targeted medicine
Eigil Kjeldsen from Aarhus University Hospital gives an expert perspective on the drive towards precision and targeted medicine for acute leukaemia
Chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML): Leukaemia patients watching and worrying
Bethany Torr, campaigns and advocacy officer at Leukaemia Care discusses the impact of chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML) on patients
Zika virus could help combat brain cancer
New research has found that the Zika virus could be an alternative for treatment of glioblastoma, the most common and aggressive kind of brain cancer in adults
Need for supportive care in oncology will increase during the next decade
The need for supportive care in oncology will increase as patients continue to live longer and cancer progresses to become more like a chronic disease
Supportive care increases patient quality of life, improves their chances of completing treatment, can reduce costs for healthcare institutions, and is fundamentally necessary given that...
Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics
Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics
Acute myeloid leukaemia (AML) is the cancer of the myeloid precursor stem cells characterised by the appearance of immature, abnormal myeloid cells in bone marrow and other...
Acute myeloid leukaemia (AML)
Acute myeloid leukaemia (AML), a form of blood cancer is placed into the spotlight by Open Access Government
Acute myeloid leukaemia (AML) is a form of blood cancer, which affects the white blood cells known as myeloid cells. It is a rapidly progressing form of leukaemia. Blood cells are formed...
Living with Leukaemia
Bethany Torr, campaigns and advocacy officer at Leukaemia Care introduces ‘Leukaemia’ and its different forms and explains how people live with the disease
Leukaemia’ is an umbrella term for cancers of the white blood cells – ‘leuk’ means white and ‘aemia’ refers to a condition of the blood. 26 people are...
Department of Pharmacotherapy and Translational Research
The Department of Pharmacotherapy and Translational Research provides classroom and clinical instruction for pharmacy students and trains graduate students in clinical translational research.
The Department of Pharmacotherapy and Translational Research is proud of its national reputation as a leader in the areas of pharmacy practice, education and clinical translational research....
Fostering and supporting excellence in clinical pharmacy practice
Islam Elkonaissi and Zahra Laftah from the UKCPA explore the British model of supporting excellence in clinical pharmacy practice
In the UK, evidence that pharmacists can provide better clinical outcomes and more efficient, consistent and sustainable services for patients, is increasing. In this article, key themes are discussed to showcase...